Provided herein in certain embodiments are compounds, pharmaceutical compositions and methods for modulating the functions of estrogen receptor alpha 36, for preventing and/or treating diseases mediated by estrogen receptor alpha 36, for preventing and/or treating osteoporosis, for inducing cell death and/or inhibiting cell proliferation and for preventing and/or treating diseases involving abnormal cell proliferation such as cancers.
在某些实施例中提供了化合物、药物组合物和方法,用于调节
雌激素受体α36的功能,用于预防和/或治疗由
雌激素受体α36介导的疾病,用于预防和/或治疗骨质疏松症,用于诱导
细胞死亡和/或抑制细胞增殖,以及用于预防和/或治疗涉及异常细胞增殖的疾病,如癌症。